PARP9 and diffuse large B-cell lymphoma: ARTD9 (PARP9/BAL1) was described as a risk factor for diffuse large B cell lymphoma (DLBCL) and therefore initially referred to as BAL1 (B-aggressive lymphoma 1) [27].